Massively Insightful: Why Dallas and Why Now
|
Massive Bio chose Dallas for its Massively Insightful Summit, a reflection of North Texas’ growing influence in healthcare and life sciences innovation. Hosted at MarketScale HQ, the event convened leaders across oncology, AI, clinical research, and investment, reinforcing a clear theme: this ecosystem is not just expanding, it is evolving with intention.
In opening the panel, Eric B. Moore, Chief Communications Officer of BioNTX, highlighted the region’s strength at the intersection of technology, capital, and talent, supported by collaborative leaders like HealthWildcatters. Moderated by Jovelyn Castellanos and featuring James Wang and Panna Sharma, the panel emphasized connected systems, aligned leadership, and the power of true collaboration grounded by impactful patient stories.
Dallas was chosen for a reason and the momentum is only building, with the Massively Insightful Podcast extending these conversations forward.
|
Inside Innovation: How Branding & Regulatory Strategy
Drive Life Science Innovation
|
We often talk about innovation in terms of science and technology, but how that innovation is named, understood, and trusted is just as critical.
In this episode of Inside Innovation, presented by BioNTX, host Eric B. Moore sits down with Scott Piergrossi, Brian Frasca, and Jack Stohlquist of Brand Institute, the Official Branding and Innovation Partner of BioNTX, to explore how naming and regulatory strategy shape commercialization success in life sciences.
|
BioNTX Presents: 2026 Legal Forum — Sponsored by Sheppard
|
BioNTX was proud to host our second annual Legal Forum, bringing together attendees from across the North Texas life sciences ecosystem, from emerging companies to legal experts, investors, and industry partners.
The discussion underscored a shared reality: the legal and regulatory landscape is evolving quickly, and staying ahead requires both insight and collaboration. A highlight of the program was Dominick DiSabatino, Partner, Life Sciences, FDA and Healthcare Regulatory Compliance, who delivered a timely overview of key issues from medical product pricing to shifting regulatory pathways and enforcement trends.
Thank you for your support
|
BIO BREAK: North Texas Connections in Life Sciences
|
BIO BREAK offers the life sciences community an opportunity to network, exchange insights, and foster professional connections. Attendees can engage with peers, discuss emerging trends, and build relationships that support collaboration and innovation across the ecosystem.
|
PCCP: Building Our Talent Network
April 8, 2026
|
Presents
Peer Career Connect Program
|
The Peer Career Connect Program (PCCP) is a platform for professionals navigating career transitions and for employers seeking talent in life sciences and related industries. PCCP facilitates meaningful connections, peer learning, and knowledge sharing to help jobseekers explore opportunities and employers connect with qualified candidates.
Open to professionals at all career stages and employers across sectors including biopharma, digital health, aerospace, research, engineering, logistics, and manufacturing, PCCP provides a space to exchange insights, explore career paths, and build valuable professional relationships in a collaborative and results focused environment.
|
Thank you for your support
|
Summer Sizzler Happy Hour with the
BioNTX Facilities Committee: Connect & Unwind
May 20, 2026
|
Join the BioNTX Facilities Advisory Committee for an afternoon of networking and refreshments at McMillan James Equipment Company’s state-of-the-art facility.
Connect with fellow life science professionals, explore the facility, and enjoy the chance to unwind with the BioNTX community as we continue building momentum for Life Science in North Texas.
|
Thank you for your support
|
2026 iC³ Summit: North Texas’s Premier Life Science Gathering
September 24 - 25, 2026
|
The BioNTX iC³ Life Science & Healthcare Innovation Summit is North Texas’s premier convening for the region’s bioscience and healthcare community. Each year, we bring together industry leaders, pioneering researchers, investors, entrepreneurs, and innovators to share insights, explore emerging trends, and collaborate on the next breakthroughs in life sciences and healthcare.
At iC³ 2026, you will have the opportunity to engage with thought leaders, connect with peers, and participate in conversations that are shaping the future of healthcare innovation in North Texas and beyond. Whether you are looking to gain knowledge, showcase your work, or build meaningful partnerships, iC³ provides the platform to make an impact.
Thank you for your support
|
The Cleanroom Center Launch: Tours, Demos, and Expert Talks
April 8 - 9, 2026
|
The Cleanroom Center is celebrating its grand opening on April 8th with an event featuring BioNTX’s CEO, Gina Ford as a guest speaker.
Attendees will have the opportunity to explore tour demos and network with life science leaders and innovators shaping North Texas’ biotech community.
|
The Cleanroom Center is hosting a Fireside Discussion Series on April 9th, where cleanroom owners, industry experts, and design professionals share real-world insights on designing, building, and operating cleanrooms.
Whether you are planning your first cleanroom or expanding an existing facility, this is a great opportunity to gain insight and make meaningful connections.
|
Lyda Hill Philanthropies Supports Dallas ISD
STEM Field Trip Program
|
With funding from Lyda Hill Philanthropies, Dallas ISD has launched “Learning Voyages,” giving more than 48,000 students the chance to take STEM-focused field trips this spring. Students from grades 1, 2, 5, and 7 will visit destinations like the Dallas Arboretum, Dallas Zoo, Environmental Education Center, and Perot Museum of Nature and Science. The program removes financial and logistical barriers, reinforces classroom lessons with hands-on experiences, and will expand to all grade levels in the 2026–27 school year.
|
Alloy Therapeutics Announces Antibody Platform
Collaboration with AbbVie
|
Alloy Therapeutics has entered a multi-year agreement with AbbVie to develop a next-generation antibody discovery platform targeting difficult-to-address biology. Alloy will receive upfront and milestone-based payments tied to platform delivery. The collaboration expands AbbVie’s research capabilities while reinforcing Alloy’s focus on enabling partners through platform-based drug discovery. Alloy’s ATX-Gx platform is already widely used across 200+ therapeutic programs, with continued investment in new tools to advance antibody development.
|
AstraZeneca’s Imfinzi Approved in EU for Gastric & GEJ Cancers
|
AstraZeneca’s Imfinzi, in combination with FLOT chemotherapy, has been approved in the European Union for adults with resectable early-stage and locally advanced gastric and gastroesophageal junction (GEJ) cancers. The approval is based on the Phase III MATTERHORN trial, which showed statistically significant improvements in event-free and overall survival. Gastric cancer remains a leading cause of cancer death worldwide, with nearly one million new cases diagnosed annually.
|
Colossal Biosciences Opens Dallas Headquarters to Media
|
Colossal Biosciences has opened its Dallas headquarters to journalists for the first time, offering a look inside its genome engineering lab focused on reviving extinct species. The facility combines advanced gene-editing labs with immersive design—from clean rooms and precision equipment to large-scale visual displays—underscoring the company’s mission to bring de-extinction closer to reality.
|
Etira Publishes New Findings on ERX-41
in Inflammatory Breast Cancer
|
Etira has published a new open-access study in Biomolecules highlighting the activity of ERX-41 in Inflammatory Breast Cancer, an aggressive and hard-to-treat subtype of breast cancer. The study demonstrates that ERX-41 inhibits tumor cell growth and invasion, induces apoptosis, and activates stress response pathways, with results confirming LIPA as a key therapeutic target. Preclinical models also showed strong tumor suppression.
|
Nanoscope Therapeutics, Inc. Publishes Study on Measuring
Vision Improvements in Retinal Degeneration
|
Nanoscope Therapeutics, Inc. announced the publication of a new peer-reviewed observational study in Documenta Ophthalmologica. The study advances methods to assess meaningful vision improvements in patients with severe vision loss due to retinal degeneration. It highlights tools that capture functional improvements and patient experience, supporting their use in standard retinal care workflows.
|
Secretome Therapeutics’s STM-01 Receives
FDA Fast Track Designation for HFpEF
|
Secretome Therapeutics announced that the U.S. FDA has granted Fast Track designation to STM-01, its neonatal cardiac progenitor cell therapy, for the treatment of Heart Failure with Preserved Ejection Fraction. HFpEF affects millions globally and currently has limited disease-modifying treatments.
|
TriCelX Files IND and Seeks RMAT Designation
for XytriX™ in Knee Osteoarthritis
|
TriCelX announced the submission of a Phase 1/2 Investigational New Drug (IND) application to the FDA for XytriX™, an allogeneic umbilical cord-derived mesenchymal stem cell (MSC) therapy targeting knee osteoarthritis. At the same time, the company requested Regenerative Medicine Advanced Therapy (RMAT) designation, a pathway designed to expedite development for promising therapies addressing serious conditions.
|
Baker Tilly Named Deltek Services Partner
of the Year for Sixth Consecutive Year
|
Baker Tilly, a leading advisory, tax, and assurance firm, has been named Deltek’s Services Partner of the Year, marking its sixth consecutive year receiving this recognition. The award highlights the firm’s exceptional service delivery and measurable impact supporting government contracting clients.
|
Ecolab to Acquire CoolIT Systems to
Expand Data Center Cooling Capabilities
|
Ecolab announced that it has entered into a definitive agreement to acquire CoolIT Systems, a fast growing and high margin leader in liquid cooling technology for next generation AI data centers. The acquisition is expected to strengthen Ecolab’s Global High Tech growth engine. The transaction will position Ecolab as a comprehensive cooling solutions provider within the rapidly expanding data center market.
|
PSC Biotech Partners with Blue Ocean Robotics
to Advance Cleanroom Disinfection
|
PSC Biotech Corporation has partnered with Blue Ocean Robotics to expand access to the UVD Robot Pharma platform across the United States, Australia, and Singapore. As distributor, PSC Biotech will bring autonomous UV-C disinfection technology to pharmaceutical manufacturers aiming to strengthen Annex 1 readiness and contamination control.
Designed for GMP cleanrooms, the UVD Robot Pharma enables standardized, automated disinfection with full digital traceability, reducing manual processes and improving efficiency.
|
Polsinelli Embeds AI into Core Legal Workflows
|
Polsinelli has expanded its use of Fortress AI across its transactional, regulatory, and litigation practices, building on its earlier adoption of the Project Fortress matter management platform. By embedding AI directly into core workflows, documents, and live matters, the firm is advancing its use of artificial intelligence in legal operations.
|
Baylor Researcher Advances Cancer Research Abroad
Through Fulbright Specialist Program
|
Jonathan Kelber, Ph.D., associate professor of biology at Baylor University, has been named to the Fulbright Specialist Program. He is serving in Slovakia to advance cancer research at Comenius University’s Jessenius Faculty of Medicine, collaborating with local scientists and engaging high school and university students to promote STEM education. His work also strengthens international research partnerships and fosters opportunities for scientific collaboration between the U.S. and Slovakia.
|
UNT Health Fort Worth Expands Forensic Nursing Training
|
UNT Health Fort Worth’s College of Nursing has launched a no cost Forensic Nursing Microcredential to train registered nurses in providing specialized care to survivors of sexual assault and interpersonal violence. The program equips nurses with trauma informed clinical skills through a mix of in person learning, online coursework, and hands on training. It also helps remove barriers to certification while expanding access to forensic nursing care across North Texas.
|
UTA Expands Antibody Discovery with
First-in-U.S. Beacon Technology
|
The University of Texas at Arlington, a Carnegie R1 research institution, is continuing to expand its research capabilities as the first U.S. university to acquire the Beacon Discovery instrument from Bruker Cellular Analysis.
The technology is now being used by researchers at UTA’s Institute of Biomanufacturing and Precision Medicine for North Texas (IMPRINT) to accelerate the discovery of new antibodies. By connecting early-stage antibody discovery more directly with existing drug development pipelines, it strengthens both academic research and industry collaboration.
|
(from left to right) Jon Weidanz, PhD, MPH and Soroush Ghaffari, PhD of UTA's IMPRINT Lab with the Beacon Discovery instrument.
|
UT Dallas Researchers Join Effort to
Advance Lymphatic Disease Diagnostics
|
A team from the University of Texas at Dallas is contributing to the Advanced Research Projects Agency for Health’s LIGHT program, aimed at developing the first comprehensive diagnostic toolkit for lymphatic diseases, which affect an estimated 10 million people in the United States.
Led by Dr. Zhenpeng Qin, Eugene McDermott Distinguished Professor of mechanical engineering, the UT Dallas group is identifying molecules such as specific proteins that could signal the presence of lymphatic disorders. Their work focuses on detecting these biomarkers through blood samples to improve early diagnosis and routine screening.
|
UTSW Research Suggests Fracture Risk Tool Can
Guide Parathyroid Surgery
|
UT Southwestern researchers found that the Fracture Risk Assessment Tool (FRAX) may help identify patients with primary hyperparathyroidism who could benefit from parathyroidectomy. FRAX scores predicted fracture risk even without bone density data and could support more personalized treatment decisions for patients.
Analyzing nearly 60,000 adults with PHPT, researchers found that FRAX scores reliably predicted which patients would gain fracture protection from surgery, even when bone density data were unavailable. The findings also highlight that some patients who do not meet current surgical guidelines may still face elevated fracture risk, underscoring FRAX’s potential to support more personalized treatment decisions.
|
UT Tyler Engineer Receives NSF CAREER Grant
for Smart Plant Sensors
|
Dr. Shawana Tabassum, Mary John and Ralph Spence Assistant Professor of Electrical and Computer Engineering at The University of Texas at Tyler, has received a National Science Foundation CAREER grant to develop compact, biodegradable sensors that can monitor plant nitrogen levels in real time. The sensors aim to help farmers apply fertilizer more efficiently, reduce environmental impact, and support sustainable agriculture.
|
FUNDING & MENTORSHIP OPPORTUNITIES
|
Morgan Stanley Inclusive & Sustainable Ventures
Morgan Stanley supports early-stage startups and nonprofits developing market-ready solutions for a more inclusive and sustainable future, with impact in areas like health, the environment, education, and economic empowerment.
Applications due March 30th
|
Prototype Fund
The Prototype Fund at the Texas Tech Innovation Hub supports early-stage tech startups in developing prototypes or MVPs based on customer discovery insights.
Applications due May 1st
|
Startup Prize: Health 2026
Startup Prize is a national, founder-first program designed to support early-stage companies preparing for commercialization. Startup Prize connects founders with experienced mentors, practical guidance, and investor and ecosystem connections.
Applications due May 15th
|
2026 Health Wildcatters Accelerator Program
The Health Wildcatters Accelerator Program continues to be ranked among the greatest in the nation according the Seed Accelerator Rankings Project. If you are looking to take your startup to the next level, the Health Wildcatters Accelerator Program is your next step.
Applications due May 30th
|
Upcoming Events & Opportunities
|
Texas Life Sciences Summit
Join THBI to explore explore the factors driving the growth of the life sciences ecosystem in Texas, facilitate collaborations across the industry, and advance the economic impact of innovation.
March 31st - April 1st | Austin, TX
|
Bioengineering & Health Sciences Convergence Summit
Join UTD to explore cutting-edge technologies, transformative research and collaborative strategies that will redefine patient care and medical innovation.
April 1st | Richardson, TX
|
2026 Biofest Military Health Tour
Join BioMedSA to gain insight into the cutting-edge facilities, advanced medical research, and innovative healthcare solutions that support our nation’s current service members and veterans.
April 7th | San Antonio, TX
|
Health Wildcatters Alumni Reunion
and Community Happy Hour 2026
Join Health Wildcatters alums for drinks, laughs, and good vibes at a fun in-person happy hour!
April 8th | Dallas, TX
|
The Cleanroom Center Grand Opening
The Cleanroom Center is celebrating its grand opening with an event featuring BioNTX’s CEO, Gina Ford. Attendees will have the opportunity to explore tour demos and network with leaders shaping North Texas’ biotech community.
April 8th | Dallas, TX
|
The Cleanroom Center - Fireside Chats
Join The Cleanroom Center for the world’s first multi-vendor cleanroom showroom and gain insight on real-world experiences on what it actually takes to design, build, and operate a cleanroom.
April 9th | Dallas, TX
|
Thank you for your support!
|
|
